As the debate over mifepristone makes its way to the Supreme Court, the pharmaceutical industry has raised concerns that ruling against the FDA could chill the development of new drugs.
on Friday that sided with the anti-abortion groups and overturned the FDA's decisions about mifepristone. His decision was immediately appealed by the Department of Justice.a group of pharmaceutical executives and companiesurging the appellate court to block the preliminary injunction and allow the FDA's approval of mifepristone to remain in place.
Late Wednesday night, the 5th Circuit dialed back the original preliminary injunction, saying that it was too late to challenge the FDA's 23-year-old original approval of mifepristone. "Industry members are wondering, well, if a judge can do that, what else can't a judge, perhaps with an ax to grind, do?" he saidBringing new drugs to market is already expensive and time-consuming. To research and develop a new medical product can cost hundreds of millions of dollars and years of clinical trials.
Take vaccines as an example, said Allison Whelan, a law professor at Georgia State University."This is essentially saying, 'Here is a way that you could stop these vaccines that you disagree with,' not for safety and efficacy reasons, but for other reasons," she said.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Abortion issue returns to Supreme Court as DOJ fights ruling on FDA’s pill approvalThe Biden administration will ask the Supreme Court to lift newly imposed court restrictions on a popular abortion pill, sending the pregnancy-termination issue back to the high court less than a year after its historic decision overturning Roe v. Wade was supposed to return the issue to the states to regulate.
Read more »
DOJ asks Supreme Court to block federal court rulings restricting abortion pillsNEW: The Justice Department asked the Supreme Court to block federal court rulings that imposed restrictions on the widely used abortion pill mifepristone.
Read more »
Abortion pill access may continue even if FDA loses US court battleThe abortion pill mifepristone is used in more than half of all abortions in the country.
Read more »
Federal appeals court limits use of abortion pill, but doesn’t ban its FDA approvalA federal appeals court Wednesday ruled the abortion pill mifepristone could still be dispensed up to seven weeks of pregnancy, but the panel blocked its delivery through the mail — for now.
Read more »
Legal abortions fell 6% in six months after Supreme Court overturned RoeLegal abortions in the US dropped more than 6% in the six months after SCOTUS overturned Roe v. Wade, a testament to the new rules and regulations that now vary from state to state. There were an average of 5,377 fewer abortions per month.
Read more »
What can the Supreme Court Dobbs decision tell us about abortion pill challenges?The Supreme Court could be roped back into an abortion dispute due to conflicting rulings in lower courts over the drug mifepristone, nearly a year after a leak paved the way for overturning Roe v. Wade.
Read more »